← All thesesAEHRUnattractiveHigh convictionTuesday 3 November 2026עברית

Aehr Test Systems

This is the archived full research. Read the story

A small California maker of machines that heat and power chips for hours so the weak ones fail in the factory, now selling mostly to AI chip makers.

Our viewUnattractive High conviction
The scores
The profile · 1-4
Growth2/4 ↑

Revenue fell two years to $50.0M, then rose 200% to a record $33.0M in one quarter; one quarter is not yet an engine.

Business quality3/4 ↑

The only supplier shown doing wafer-level AI burn-in, but on one unnamed customer, with rivals in silicon carbide and package level.

Financial position3/4 ↑

Net cash of $105.1M and no debt, raised from share sales rather than operations, which used $3.1M in the quarter.

Execution record2/4 ↑

The fiscal 2024 guide fell from $100M to $66M in two cuts; fiscal 2026's was met, one clean year since.

Per share capture3/4 →

Shares up about 17% in four years with flat revenue, but the recent sales were made at high prices and nothing ranks ahead.

Potential2/4 ↑

A large AI market, but growth past fiscal 2027 needs customers who have not ordered, and the burn-in slice is unmeasured.

Risk profile2/4 →

Three customers were half of revenue, and the guide rests on two unnamed buyers' cancellable orders.

Valuation1/4 ↑

About 23.5 times sales, 573% of a three-stage value near $9.20 at an 8% return: priced for perfection, beyond the 20% margin.

Evidence quality3/4 →

Revenue, cash and insider sales are filed; customers, the AI share and every order since May are management's own.

The bet · 2-3 years
Priced for success0.6×

If it works 0.6× · if it fails you keep up to 5%.

The Verdict

We rate Aehr Test Systems Unattractive. It is the one company shown screening AI chips while still on the wafer, with orders covering nearly all of this year's forecast, but sales fell two years running before this, a few unnamed buyers carry it and rivals offer the same test for finished chips, so the business is mixed. The price sits far above our value and our best case, while the production order we wait for has not come. As a bet it is fragile: if the AI orders stop, shareholders keep little beyond the cash.

The long caseIf AI chips keep packing more dies and memory into one package, screening each die before packaging pays, and Aehr is the one shown doing it.

How we weighed it

The price against our value

Against it

Price at 582% of our value

The price sits far above our value and above the bull case.

The business

Cuts both ways

Mixed

A mixed business: a unique tool, with sales that fell for two years.

Growth against what the price assumes

In its favour

Orders cover nearly all of this year's raised forecast.

What could go wrong

Against it

A few buyers carry it, rivals offer burn-in for finished chips and margins are under pressure.

Against competitors

Cuts both ways

No filed rival compares directly; the rise came from the price, not sales per share.

How its group is behaving

Cuts both ways

Chip-equipment names move together on news about chipmakers' spending.

The latest news and report

In its favour

The last report raised the forecast and recovered the margin.

The evidence under this - 6 claims
C16management claimmedium confidence
Management says its lead wafer-level AI customer moved all production burn-in from system-level test to wafer level and doubled its systems; on August 12, 2026 it announced a $22M follow-on order from that customer, to ship over six months to its manufacturing partner in Taiwan.
against this

The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).

current state · 2026-08-12written 2026-10-06
C08management claimmedium confidence
Fourth-quarter bookings were a record $60.7M and second-half bookings $97.9M; first-quarter fiscal 2027 bookings were $46.7M, 1.4 times revenue, and effective backlog including orders to November 1 was $109.3M, against $100.6M after the fourth quarter.
against this

Bookings and effective backlog are the company's own measures; the filed backlog at the year end was $80.6M and cancellable (C07).

  1. 2026-11-03editedQ1 fiscal 2027 release: bookings of $46.7M exceeded revenue by over 40% and effective backlog rose to $109.3M after $33.0M was shipped.
current state · 2026-07-14written 2026-10-06
C36inferencehigh confidence
On 32.62M shares at $51.47 the market value is about $1.68B and, less $105.1M of cash, the company value about $1.57B: about 10.5 times the raised $150M guide and about 52 times its pretax target of at least 20% of revenue, $30M.
against this

The vendor put company value at $3.26B on an older share count, 63.9 times trailing sales at the October 5 close (S11); the share count here is still July's, and the first-quarter 10-Q will give the current one.

  1. 2026-10-23editedre-struck at the 22 October close of $55.65, 46.7% below the 5 October close it was struck at
  2. 2026-11-03editedRe-struck at the 2 November close of $51.47 (from $55.65) with September's cash of $105.1M and the raised $150M guide; the share count is still July's, the 10-Q not yet being filed.
current state · 2026-11-02written 2026-10-06
C38facthigh confidence
Analysts' consensus, from two of them, is $135.2M for fiscal 2027 and $135.9M for 2028, flat; one analyst has $210.3M for 2029. All six ratings in FMP's series are buys, while the snapshot shows one buy and two holds.
current state · 2026-10-06written 2026-10-06
C14facthigh confidence
In July 2023 Aehr guided fiscal 2024 to at least $100M of revenue and $28M of net income; it cut to $75M to $85M in January 2024 and to more than $65M in March, and delivered $66.2M.
historical · FY2024written 2026-10-06
C24factmedium confidence
Semight and Nexustest each sell a nine-wafer burn-in system for silicon carbide and gallium nitride wafers under the same model numbers, and Pentamaster sells a six-to-eight-wafer one; none of the three pages offers wafer-level burn-in of AI processors.
current state · 2026-10-06written 2026-10-06
01

The company

Some chips are weak from birth and fail in their first weeks of use. Burn-in finds them by running chips hot and under power for hours in the factory.

Aehr's main machine does this to whole wafers, the discs chips are cut from, nine at once, through a contact plate built for each chip design. A second line, bought in 2024, handles finished chips.

Its biggest AI customer used to test chips after packaging and now does all its burn-in on the wafer instead.

The evidence under this - 4 claims
C01facthigh confidence
Aehr makes burn-in systems, which run chips hot and under power for hours to make weak ones fail before they ship: FOX-XP wafer-level systems with custom WaferPak full-wafer contactors, and, since buying Incal, Sonoma package-level systems for AI processors. One segment; 138 employees at May 2026, 43 in research.
current state · 2026-05-29written 2026-10-06
C03facthigh confidence
Fiscal 2026 revenue was $28.7M of systems, $14.9M of WaferPak and DiePak contactors and $6.4M of services; by line, $31.5M (63%) wafer-level and $18.5M (37%) package-level, against $1.6M package-level in 2024.
historical · FY2026written 2026-10-06
C16management claimmedium confidence
Management says its lead wafer-level AI customer moved all production burn-in from system-level test to wafer level and doubled its systems; on August 12, 2026 it announced a $22M follow-on order from that customer, to ship over six months to its manufacturing partner in Taiwan.
against this

The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).

current state · 2026-08-12written 2026-10-06
C26facthigh confidence
Teradyne's system-level testers screen devices after wafer and package test, the step Aehr's lead AI customer says it no longer needs; Teradyne's 10-K does not mention burn-in.
current state · 2026-02-19written 2026-10-06

How it makes money

Aehr earns most of its money selling the machines: $28.7M of last year's $50.0M. The contact plates made for each chip design brought in $14.9M, and are bought again whenever a customer changes its chip, so management treats them as repeat business. Service brought the rest.

The money comes from very few hands: five customers paid 70% of last year's sales, and none is named.

The evidence under this - 3 claims
C03facthigh confidence
Fiscal 2026 revenue was $28.7M of systems, $14.9M of WaferPak and DiePak contactors and $6.4M of services; by line, $31.5M (63%) wafer-level and $18.5M (37%) package-level, against $1.6M package-level in 2024.
historical · FY2026written 2026-10-06
C43management claimmedium confidence
Management says power supply vendors raised prices 40%, and that consumables run about 30% of revenue.
against this

Contactors were $14.9M of $50.0M, 30%, in fiscal 2026 (C03), which agrees; the 40% is not in the 10-K.

current state · 2026-07-14written 2026-10-06
C04facthigh confidence
The five largest customers were 70% of fiscal 2026 revenue, against 77% in 2025 and 93% in 2024; three customers were 26%, 14% and 11% in 2026, and in 2024 two were 67% and 17%.
historical · FY2026written 2026-10-06
Where the money comes from, stream by stream
StreamShare of sales (FY2026)How it earns it
Systems57.4%FOX-XP, FOX-NP and Sonoma burn-in systems, booked on shipment or acceptance.
WaferPak and DiePak contactors29.8%Custom contactors made for each chip design, bought again as designs change; management calls them consumables.
Services12.8%Installation, support and spare parts on installed systems.

Who runs it

Gayn Erickson has run Aehr since 2012, through the car-chip boom and the turn to AI. The founder, Rhea Posedel, is still chairman.

Insiders own about 4.6%. Bonuses paid nothing last year, and long-term share awards pay on reaching a sales target by June 2027. Insiders sold 743,893 shares in the past year, none under a pre-set selling plan, and bought none.

The evidence under this - 4 claims
C48facthigh confidence
Aehr is led by Gayn Erickson, chief executive since 2012; Chris Siu, finance chief since 2023; and Rhea Posedel, the founder and chairman since 1977.
current state · 2026-09-09written 2026-10-06
C32facthigh confidence
Directors and officers owned 1,488,042 shares, 4.6%, in August 2026; the founder and chairman 477,714 and the chief executive 259,996; BlackRock held 6.4% and Jane Street 5.0%.
current state · 2026-08-27written 2026-10-06
C33facthigh confidence
Fiscal 2026 bonuses on revenue and profit paid nothing; long-term share units vest on a cumulative revenue target in named markets through June 2027, and one 2026 tranche was cancelled when its goals were missed.
historical · FY2026written 2026-10-06
C31facthigh confidence
Insiders made 74 open-market sales of 743,893 shares in the year to October 2026, none under a Rule 10b5-1 plan and with no purchases, clustered from April 9 to 22 at $66 to $100 and from August 12 to 17 at $127 to $144.
current state · 2026-10-06written 2026-10-06
02

Why it wins, and who could beat it

Why customers come back

An AI chip is now packaged with several other chips and stacks of memory, so one weak chip can spoil an expensive package. Intel has said many defects still get past the wafer stage. Aehr says catching them earlier pays many times over, though that figure is its own.

Its edge is know-how in powering a whole wafer at once, kept mostly secret. Nobody else is shown doing it for AI chips; for car chips, a Chinese rival sells a similar machine and won the first patent ruling.

The evidence under this - 5 claims
C29factmedium confidence
Intel's test fellow wrote that known-good die out of wafer test is critical to chiplet packages and that a significant number of defects still get past wafer test to package test; onsemi lists wafer-level burn-in in its silicon carbide screening flow.
historical · 2020 to 2024written 2026-10-06
C17management claimmedium confidence
Aehr's chief executive puts the buyer's case as yield: if 1% of dies are weak, a package of eight carries about an 8% loss, while burn-in costs about 0.1% of the package.
against this

No buyer has published what a failed AI package costs it; Intel says defects still escape wafer test to package test but puts no figure on it (S22).

current state · 2026-07-14written 2026-10-06
C22facthigh confidence
Aehr's 10-K names no competitor; it says it faces established rivals with greater resources, relies mainly on trade secrets, and holds 125 patents expiring from 2028 to 2045.
current state · 2026-07-27written 2026-10-06
C24factmedium confidence
Semight and Nexustest each sell a nine-wafer burn-in system for silicon carbide and gallium nitride wafers under the same model numbers, and Pentamaster sells a six-to-eight-wafer one; none of the three pages offers wafer-level burn-in of AI processors.
current state · 2026-10-06written 2026-10-06
C23facthigh confidence
A Chinese court dismissed Aehr's patent claims against Suzhou Semight in December 2025 for insufficient evidence; the appeal was heard on June 2, 2026, and management says a Taiwan silicon carbide customer chose Aehr over Semight.
current state · 2026-07-27written 2026-10-06

The threat

The main alternative is to test after packaging, as Teradyne's and Advantest's machines do; Aehr's lead AI customer stopped doing that. For finished AI chips, rivals such as AEM in Singapore already sell burn-in machines, and AEM says a large AI chip designer chose it. For car chips, three Asian makers sell wafer machines like Aehr's.

The evidence under this - 3 claims
C26facthigh confidence
Teradyne's system-level testers screen devices after wafer and package test, the step Aehr's lead AI customer says it no longer needs; Teradyne's 10-K does not mention burn-in.
current state · 2026-02-19written 2026-10-06
C24factmedium confidence
Semight and Nexustest each sell a nine-wafer burn-in system for silicon carbide and gallium nitride wafers under the same model numbers, and Pentamaster sells a six-to-eight-wafer one; none of the three pages offers wafer-level burn-in of AI processors.
current state · 2026-10-06written 2026-10-06
C25factmedium confidence
Package-level burn-in for AI chips is sold by others: AEM says its AMPS-BI was chosen as the plan-of-record by a major fabless AI chip maker in 2024; Advantest sells a system-level test and burn-in platform; Trio-Tech's burn-in board sales rose 58.4% in its year to June 2026.
current state · 2026-09-24written 2026-10-06

The rivals: TER, TRT, and 3 more that are private, in-house or listed abroad.

Who else does this, rival by rival
TickerRivalWhere it competesHow far alongPriced against it
TERSystem-level test after packaging, from Teradyne and AdvantestPriced against it: Different productWafer-level burn-inOn saleDifferent product
PrivateSemight and Nexustest nine-wafer burn-in systemsPriced against it: PrivateWafer-level burn-inOn salePrivate
AEM's automated burn-in for AI processorsPriced against it: Listed abroadPackage-level burn-inOn saleListed abroad
TRTTrio-Tech's burn-in boards and systemsPriced against it: Same productPackage-level burn-inOn saleSame product
Pentamaster's Trooper-BI wafer-level burn-inPriced against it: Listed abroadWafer-level burn-inOn saleListed abroad
03

How big it could get

How big this could get

Chip-testing machines of all kinds sell for about $15.3B a year, on the industry group SEMI's forecast for 2026, rising to $20.8B by 2028. Aehr sold $50.0M last year.

Nobody outside the company measures how much of that is burn-in, so the true size of Aehr's market is unknown. What is measured is the driver: TSMC, which makes most AI chips, expects its AI chip sales to grow by well over half a year until 2029.

The evidence under this - 3 claims
C27estimatemedium confidence
SEMI forecasts semiconductor test equipment sales up 31.0% to $15.3B in 2026 and $20.8B in 2028, after 55.3% in 2025, citing AI and high-bandwidth memory; it does not report burn-in separately.
against this

SEMI's 2025 figure moved from $11.2B to about $11.7B in seven months, and it counts all test equipment, not burn-in (S18, S19).

forwardwritten 2026-10-06
C28management claimmedium confidence
TSMC said AI accelerators were high-teens percent of its 2025 revenue and raised its forecast for their revenue growth to a mid-to-high 50s percent a year from 2024 to 2029; in July 2026 it said demand was stronger than that.
against this

TSMC is a supplier with a stake in the AI story; the growth rate is its forecast, not its customers' orders.

forwardwritten 2026-10-06
C46management claimlow confidence
Management describes burn-in as the part of semiconductor test growing most quickly right now.
against this

SEMI does not split out burn-in, so no outside measure confirms it (S19).

current state · 2026-07-14written 2026-10-06

Who has signed

Since May the lead AI customer ordered $22M of wafer machines, a large internet company $41M of the finished-chip machines, and a light-chip customer two more systems. Car-chip customers added more than $8M.

None of these buyers is named, and the company says most orders can be cancelled with small penalties.

The evidence under this - 5 claims
C16management claimmedium confidence
Management says its lead wafer-level AI customer moved all production burn-in from system-level test to wafer level and doubled its systems; on August 12, 2026 it announced a $22M follow-on order from that customer, to ship over six months to its manufacturing partner in Taiwan.
against this

The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).

current state · 2026-08-12written 2026-10-06
C18management claimmedium confidence
Management says its hyperscale customer placed a record $41M Sonoma order in April, that a Sonoma system sells for about $600,000 to $700,000 with consumables, and that this customer plans a second device at twice the power. On the November 2 call management said it ships and installs more than a dozen Sonoma systems a month, that the customer's second processor has qualified on Sonoma with follow-on orders in October for an anticipated production ramp in calendar 2027, and that the customer forecasts it will reach higher volumes than the first.
against this

The customer is unnamed and no customer filing names Aehr (S01).

  1. 2026-11-03editedQ1 fiscal 2027 call: more than a dozen Sonoma systems a month, second processor qualified with follow-on orders; all still management's account of an unnamed customer.
current state · 2026-07-14written 2026-10-06
C20management claimmedium confidence
Aehr announced follow-on FOX-XP orders from its lead silicon photonics customer on July 9 and August 4, 2026, the second a nine-blade system at up to 3,500 watts a blade, to ship in the first half of 2027.
current state · 2026-08-04written 2026-10-06
C44management claimmedium confidence
Aehr announced more than $8M of silicon carbide orders on July 14, 2026, including WaferPaks from its lead silicon carbide customer and a direct order from one of the largest automakers.
current state · 2026-07-14written 2026-10-06
C07facthigh confidence
Backlog was $80.6M at May 29, 2026, against $15.2M a year earlier, and $100.9M at September 25, 2026 after $33.0M of revenue in the quarter; the 10-K says most purchase orders can be cancelled or rescheduled with limited penalties.
  1. 2026-11-03editedQ1 fiscal 2027 release: backlog $100.9M at September 25; the cancellation terms are the 10-K's, and the quarter's 10-Q is not yet filed.
current state · 2026-09-25written 2026-10-06
04

The results

The numbers

Is it growing?Fast

Sales grew 27% over the twelve months to Sep 2026, faster than the −15% in the year to May 2026.

May 2022: $50.8MMay 2023: $65.0MMay 2024: $66.2MMay 2025: $59.0MMay 2026: $50.0M12 mo to Sep 2026: $72.0M$50.8M$72.0M
Is it profitable?Losing

Operating margin is −5.6%, down from 15% in the year to May 2024.

May 2022: 15%May 2023: 21%May 2024: 15%May 2025: −9.6%May 2026: −28%12 mo to Sep 2026: −5.6%15%−5.6%
Does growth pay off?Costly

Running costs take 47¢ of each sales dollar, up from 31¢ in the year to May 2022.

May 2022: 31¢May 2023: 30¢May 2024: 34¢May 2025: 50¢May 2026: 64¢12 mo to Sep 2026: 47¢31¢47¢
Does it earn good returns?Low

Shareholders' money earned 1.0% a year, down from 30% in the year to May 2022.

May 2022: 30%May 2023: 23%May 2024: 35%May 2025: −3.3%May 2026: −4.2%12 mo to Sep 2026: 1.0%30%1.0%
How long can it keep going?Long runway

It used $6.81M of cash over the last twelve months, so the $105M it holds lasts about 15.4 years at that pace.

May 2022: $1.09MMay 2023: $8.65MMay 2024: $1.01MMay 2025: −$12.4MMay 2026: −$5.38M12 mo to Sep 2026: −$6.81M$1.09M−$6.81M
How steady is it?Swingy

Yearly sales growth has ranged from −15% to +206% over the last 5 years, with sales falling in 2 of them.

May 2022: +206%May 2023: +28%May 2024: +1.9%May 2025: −11%May 2026: −15%+206%−15%
Are shares being diluted?Diluting

The share count rose 21% in 4.3 years, and pay in shares costs 9.7% of sales.

May 2022: 27.8MMay 2023: 29.2MMay 2024: 29.6MMay 2025: 29.6MMay 2026: 30.7M12 mo to Sep 2026: 33.5M27.8M33.5M
All the numbers

Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in May.

May 2022May 2023May 2024May 2025May 202612 mo to Sep 2026
Size and growth
Sales$50.8M$65.0M$66.2M$59.0M$50.0M$72.0M
Sales growth+206%+28%+1.9%−11%−15%+27%
Profit
Gross margin47%50%49%41%35%41%
Operating margin15%21%15%−9.6%−28%−5.6%
Net margin19%22%50%−6.6%−14%3.0%
What growth costs, per sales dollar
Research and development11%11%13%18%25%19%
Selling, general and admin20%19%21%31%38%28%
Pay in shares5.9%4.2%3.8%8.8%14%9.7%
Capital spending0.8%2.1%1.1%8.5%4.1%1.0%
Cash
Cash from operations$1.51M$10.0M$1.76M−$7.40M−$3.31M−$6.08M
Free cash flow$1.09M$8.65M$1.01M−$12.4M−$5.38M−$6.81M
Balance sheet
Cash and short-term investments$31.5M$47.9M$49.2M$24.5M$116M$105M
Debt$0-----
Net cash$31.5M-----
Returns and shares
Return on capital24%21%11%---
Shares (diluted)27.8M29.2M29.6M29.6M30.7M33.5M

What growth costs

Aehr has been spending ahead of its sales. Research, selling and office costs took 31 cents of each sales dollar in fiscal 2022 and 64 cents last year, on the same sales. The profit forecast needs sales to rise much faster than those costs.

The evidence under this - 2 claims
C40inferencehigh confidence
Research, selling and administration rose from 31 cents per sales dollar in fiscal 2022 to 64 cents in 2026, while revenue was flat.
derivedR&D $5.8M and SG&A $10.0M on $50.8M in FY2022 (S13); $12.6M and $19.2M on $50.0M in FY2026 (C10).
historical · FY2022 to FY2026written 2026-10-06
C09management claimmedium confidence
Aehr guided fiscal 2027 revenue of $130M to $150M, up 160% to 200%, with pretax non-GAAP net income of 18% to 22% of revenue; on November 2, 2026 it raised the outlook to $150M, triple fiscal 2026, with non-GAAP net income of at least 20% of revenue.
against this

The company guided fiscal 2024 to at least $100M in July 2023 and delivered $66.2M (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release: guide raised from $130M-$150M to $150M, not cut; non-GAAP net income target at least 20% of revenue.
forwardwritten 2026-10-06

The last report (2 Nov)

Quarter ended September 2026, filed figures.

75.2%
Growth from the quarter before
against 82.6% the quarter before that
18¢
Operating profit
per dollar of sales

In the quarter to 25 September 2026, Aehr's sales rose 200% to a record $33.0M and it made $7.2M. The share of each dollar kept after production costs recovered to 48.5% from 35.3% last year. Orders were $46.7M, 1.4 times sales.

Orders waiting to ship reached $109.3M, and Aehr raised its forecast for the year to June 2027 to $150M, triple last year. A large AI chip maker has decided to buy one wafer machine to test in a production setting; a production order would come later.

What it did to the thesisThe forecast rose instead of falling, the margin recovered and orders beat sales, so nearly all of the year is ordered. The production order we waited for has not come. The view moves from Unattractive to Neutral.

The quarter in detail

Sales growth from the previous quarter, filed figures.

Earnings per share $0.28 against $0.12 expected.

The evidence under this - 5 claims
C50facthigh confidence
Aehr's first quarter of fiscal 2027, ended September 25, 2026, had record revenue of $33.0M, up 200% from $11.0M and 75% on the quarter; GAAP gross margin of 47.5% and non-GAAP 48.5%; GAAP net income of $7.2M, $0.21 a share; bookings of $46.7M, a book-to-bill of about 1.4; backlog of $100.9M and $109.3M including orders to November 1; and cash, equivalents and restricted cash of $105.1M, with $3.1M used in operations. Contactors and related products were 41% of revenue.
against this

The 10-Q for the quarter is not yet filed, so the figures are the company's release and call, and bookings and backlog are not audited; the 10-K says most orders can be cancelled or rescheduled with limited penalties (C07).

historical · Q1 fiscal 2027, ended September 25, 2026written 2026-11-03
C08management claimmedium confidence
Fourth-quarter bookings were a record $60.7M and second-half bookings $97.9M; first-quarter fiscal 2027 bookings were $46.7M, 1.4 times revenue, and effective backlog including orders to November 1 was $109.3M, against $100.6M after the fourth quarter.
against this

Bookings and effective backlog are the company's own measures; the filed backlog at the year end was $80.6M and cancellable (C07).

  1. 2026-11-03editedQ1 fiscal 2027 release: bookings of $46.7M exceeded revenue by over 40% and effective backlog rose to $109.3M after $33.0M was shipped.
current state · 2026-07-14written 2026-10-06
C09management claimmedium confidence
Aehr guided fiscal 2027 revenue of $130M to $150M, up 160% to 200%, with pretax non-GAAP net income of 18% to 22% of revenue; on November 2, 2026 it raised the outlook to $150M, triple fiscal 2026, with non-GAAP net income of at least 20% of revenue.
against this

The company guided fiscal 2024 to at least $100M in July 2023 and delivered $66.2M (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release: guide raised from $130M-$150M to $150M, not cut; non-GAAP net income target at least 20% of revenue.
forwardwritten 2026-10-06
C19management claimmedium confidence
Management says a major supplier of AI accelerators, CPUs and network processors completed a wafer-level benchmark that beat expectations and has now decided to buy one FOX-XP test cell to evaluate in a high-volume production setting at its Taiwan assembly partner, installed in early calendar 2027 with a production decision expected within several months after; it contributes about nothing to the fiscal 2027 guide.
against this

The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
forwardwritten 2026-10-06
C47inferencemedium confidence
The raised fiscal 2027 guide of $150M needs about $8M of revenue beyond the $33.0M shipped in the first quarter and the $109.3M effective backlog, if all of that backlog ships within the year; the July arithmetic needed about $30M to $50M beyond $100.6M.
derived$150M raised guide (C09) less $33.0M first-quarter revenue and $109.3M effective backlog (C50, C08).
against this

The gap may be filled by orders booked and shipped within the year, as in fiscal 2026's second half (C15).

  1. 2026-11-03editedFirst-quarter release: $33.0M shipped plus $109.3M effective backlog leaves about $8M to find against the $150M guide, from about $30M-$50M in July.
current state · 2026-11-03written 2026-10-06
What management did with the money

Aehr sold new shares as its price rose, raising $97.4M in the year to May 2026, most of it at about $74 a share in April. It has no debt; cash was $105.1M in September after buying long-lead parts, and that cash funds the growth.

Insiders in 2026Q3: 24 purchases and 62 sales, from their Form 4 filings.

The evidence under this - 2 claims
C12facthigh confidence
Aehr sold 1.94M shares through at-the-market programs in fiscal 2026 for $97.4M net: at $25.89 in November, $39.20 in February, $40.88 in March and 812,185 shares at $73.87 in April.
historical · FY2026written 2026-10-06
C11facthigh confidence
Cash, equivalents and restricted cash were $105.1M at September 25, 2026, against $116.5M at May 29, 2026 and $26.5M a year earlier, with no debt; $3.1M was used in operations in the quarter as long-lead parts were bought.
  1. 2026-11-03editedQ1 fiscal 2027 release and call: cash $105.1M at September 25, down $11.4M on working capital for long-lead parts; still no debt.
current state · 2026-09-25written 2026-10-06
05

The price, and where we disagree

In short. Priced for perfection. The price is about 573% of what we think the business is worth, at an 8% yearly return.

Share price
$104.40
close,
Company value for each $1 of sales
63.9
its 6-year normal 4.5

The shares rose sharply over the past year, all of it from investors paying more for each dollar of sales. They hit $145.61 in August, fell by almost half in two weeks with no news, and again between 5 and 22 October, to $55.65. They closed at $51.47 on 2 November, before the results.

The results came after that close. The next test is the second quarter, due in January.

The evidence under this - 4 claims
C35facthigh confidence
The shares closed at $145.61 on August 17, 2026, fell to $76.59 by September 1 with no filing or release behind the fall, closed at $104.40 on October 5 and at $55.65 on October 22, 46.7% lower in 13 sessions and the lowest close since April 7, with no results, order release or filing in between. It closed at $64.54 on October 28 and at $51.47 on November 2, the session before the first-quarter results, 64.7% below the August 17 close.
  1. 2026-10-23editedre-struck at the 22 October close after a 46.7% fall in 13 sessions, with no company news in between
  2. 2026-11-03editedRe-struck through the 2 November close of $51.47 for the first-quarter review; the fall from the August close is now 64.7%.
current state · 2026-11-02written 2026-10-06
C37facthigh confidence
Over the 252 sessions to October 5 the price rose 223.7% while revenue per share fell 16%, so the multiple did all of it, up 285.5%; from the same starting close the price is up 72.6% at the October 22 close, with the multiple up about 105%. Trailing price to sales has a six-year median of 4.9.
  1. 2026-10-23editedre-struck at the 22 October close: the year's return and its split are recomputed from the pack's starting close
current state · 2026-10-22written 2026-10-06
C45facthigh confidence
Aehr's fiscal 2027 began on June 27, 2026 after a four-week transition period; its first quarter ended September 25 and was reported on November 2, 38 days later, with the second quarter due around January 8, 2027.
  1. 2026-11-03editedFirst quarter reported on November 2 as the calendar suggested; claim rolled to the second quarter.
current state · 2026-11-03written 2026-10-06
C31facthigh confidence
Insiders made 74 open-market sales of 743,893 shares in the year to October 2026, none under a Rule 10b5-1 plan and with no purchases, clustered from April 9 to 22 at $66 to $100 and from August 12 to 17 at $127 to $144.
current state · 2026-10-06written 2026-10-06
The betPriced for success
If it works
0.6×
from today's value, at the stated multiple
If it fails
keep up to 5%
of today's market value: at most, with what is left counted at book value
How we value it
Method
Cash the business will produce, with any shortfall raised in new shares
Required return
8%
Long-run growth
4%
Moat
An average moat
BearBaseBull
Sales growth, years 1 to 330%, 10.5%, 19.8%60%, 21.1%, 39.6%75%, 26.4%, 49.5%
Normal operating margin8.3%10.4%11.4%
Return on new capital after year ten8%12%15%
Value a share$3.44$9.20$14.73
Price
$53.57
Priced on
6 Nov
Price as a share of the base value
582%
Yearly return the price offers on the base case
4.9%
Risk check: valued at 12%, the rate for a business not yet making a profit
$3.73

Where each figure comes from

FigureSourceWhere exactly
Sales, the last twelve monthsFiled reportQuarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the four quarters to that date.
Operating margin todayFiled reportQuarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the four quarters to that date.
Tax rateOur method's ruleThe normal rate where no rate is filed to read: 25% for a US company, 21% elsewhere.
Sales per dollar of new capitalFiled reportAnnual report (10-K) for the period to 29 May 2026, filed 27 Jul 2026: the year's sales over its operating capital.
SharesFiled reportQuarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the diluted share count.
Cash and investmentsFiled reportQuarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the balance sheet on that date.
DebtFiled reportQuarterly report (10-Q) for the period to 25 Sep 2026, filed 6 Nov 2026; the balance sheet on that date.
Sales growth, years 1 to 3Analysts' forecastsFMP's consensus for the years to 29 May 2027, 29 May 2028 and 29 May 2029, as it stood when the value was struck on 10 Nov 2026: the average of 1 to 4 analysts' revenue estimates, 60%, 21.1%, 39.6%, each year held to at most 60%. FMP publishes how many analysts, not who they are.
Normal operating marginAnalysts' forecastsFMP's consensus operating margin for the year to 29 May 2029, the average of 2 analysts' estimates, 24.4%, less stock pay of 9.7% of sales and less the 4% the analysts add back on their adjusted basis: 10.8%, which the base case takes as 10.4%. FMP publishes how many analysts, not who they are.
Return on new capital after year tenOur method's ruleSet by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate.
The bear and bull casesOur method's ruleOur method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin.
PriceMarket priceFMP's closing price on 6 Nov 2026.

What each case rests on

Bear caseGrowth runs at half the analysts' path, 30%, 10% and 20%, the margin settles a fifth lower at 8.3%, and new capital earns only the 8% rate: the downturn test.

Base caseRevenue grows 60%, 21% and 40% over three years, the analysts' path (C51), held to at most 60% a year, then fades toward 4%, closing 30% of the gap each year; the margin moves to 10.4%, the analysts' year-three figure after stock pay and on the filed basis (4.4% less).

Bull caseGrowth runs a quarter above the analysts' path, 75%, 26% and 50%, the margin reaches 11.4%, and new capital earns 15%.

What moves the base value

LowerHigher
Growth in years 1 to 3, a quarter lower or higher$6.89$12.02
The normal margin, 15% lower or higher$7.79$10.64
Capital per dollar of growth, a quarter more or less$8.55$9.66
Return on new capital after year ten, at the rate or one step up$6.83$10.18
The rate, a point higher or lower$6.93$13.10
Long-run growth a point lower$8.07-

Value a share as growth and margin change

Normal margin ↓ · growth →50%75%100%125%150%
8.3%$4.42$5.51$7.32$9.51$12.05
9.4%$4.99$6.20$8.26$10.76$13.64
10.4%$5.56$6.89$9.20$12.02$15.26
11.4%$6.14$7.59$10.16$13.30$16.91
12.5%$6.71$8.30$11.14$14.60$18.59

Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.

How we read the multiple

Aehr is valued at about $1.57B, net of its cash, against $50.0M of sales last year and a forecast of $150M this year.

For the price to work:

  1. At the raised forecast, $150M, the price is about 10.5 times sales.
  2. The forecast profit before tax, at least a fifth of sales, would be about $30M.
  3. That puts the price at about 52 times that profit.
  4. Analysts expect sales to stay flat the year after, though their figures pre-date the results.

Against its own history. It sits far above its own normal, and the whole rise came from buyers paying more per dollar of sales, while sales per share fell.

The evidence under this - 4 claims
C36inferencehigh confidence
On 32.62M shares at $51.47 the market value is about $1.68B and, less $105.1M of cash, the company value about $1.57B: about 10.5 times the raised $150M guide and about 52 times its pretax target of at least 20% of revenue, $30M.
against this

The vendor put company value at $3.26B on an older share count, 63.9 times trailing sales at the October 5 close (S11); the share count here is still July's, and the first-quarter 10-Q will give the current one.

  1. 2026-10-23editedre-struck at the 22 October close of $55.65, 46.7% below the 5 October close it was struck at
  2. 2026-11-03editedRe-struck at the 2 November close of $51.47 (from $55.65) with September's cash of $105.1M and the raised $150M guide; the share count is still July's, the 10-Q not yet being filed.
current state · 2026-11-02written 2026-10-06
C09management claimmedium confidence
Aehr guided fiscal 2027 revenue of $130M to $150M, up 160% to 200%, with pretax non-GAAP net income of 18% to 22% of revenue; on November 2, 2026 it raised the outlook to $150M, triple fiscal 2026, with non-GAAP net income of at least 20% of revenue.
against this

The company guided fiscal 2024 to at least $100M in July 2023 and delivered $66.2M (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release: guide raised from $130M-$150M to $150M, not cut; non-GAAP net income target at least 20% of revenue.
forwardwritten 2026-10-06
C38facthigh confidence
Analysts' consensus, from two of them, is $135.2M for fiscal 2027 and $135.9M for 2028, flat; one analyst has $210.3M for 2029. All six ratings in FMP's series are buys, while the snapshot shows one buy and two holds.
current state · 2026-10-06written 2026-10-06
C37facthigh confidence
Over the 252 sessions to October 5 the price rose 223.7% while revenue per share fell 16%, so the multiple did all of it, up 285.5%; from the same starting close the price is up 72.6% at the October 22 close, with the multiple up about 105%. Trailing price to sales has a six-year median of 4.9.
  1. 2026-10-23editedre-struck at the 22 October close: the year's return and its split are recomputed from the pack's starting close
current state · 2026-10-22written 2026-10-06
Priced against its rivals

Only Trio-Tech International sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.

Also checked and set aside: Cohu (a substitute, not the same product).

Private or foreign rivals that cannot be priced: Suzhou Semight Instruments, Nexustest Instruments, Micro Control Company, KES Systems, Advantest, Pentamaster, AEM Holdings, Chroma ATE, ESPEC.

The bet: what it pays if it works

This is a bet that wafer burn-in becomes standard for AI chips, with a second large chip maker in production. Even then, valued at a rich but not extreme price for each dollar of sales, the company would be worth a little over half of the 5 October price this bet was struck at.

If the AI orders stop once the current orders ship, what is left is the cash and a small car-chip and light-chip business, a small fraction of today's value.

Revenue in two to three yearsFOX-XP systems neededAt the stated multiple
$140.00Mabout 15 at 100% kept0.4×
$210.00M (the big win)about 27 at 100% kept0.6×
$300.00Mabout 42 at 100% kept0.8×

To pay 2× (a Fair bet) it would need about $723.56M of revenue (about 112 FOX-XP systems); to pay 5× (a Cheap bet), about $1.81B of revenue (about 293 FOX-XP systems), at the same multiple.

The steps it has to take

  • Done Lead AI processor customer in production on wafer-level burn-in
  • Done Hyperscaler Sonoma production follow-on order
  • In progress Fiscal 2027 revenue of $150M due 2027-06-25
  • In progress Benchmark AI processor maker orders for production due 2027-06-30
  • Not started A memory maker commits to wafer-level burn-in due 2027-12-31
The detail behind the label
Rating
Expensive
the big win's payoff against the 2× and 5× lines
Cheap bet at about
≈ $14.96
86% below the price (close, )
The evidence under this - 7 claims
C19management claimmedium confidence
Management says a major supplier of AI accelerators, CPUs and network processors completed a wafer-level benchmark that beat expectations and has now decided to buy one FOX-XP test cell to evaluate in a high-volume production setting at its Taiwan assembly partner, installed in early calendar 2027 with a production decision expected within several months after; it contributes about nothing to the fiscal 2027 guide.
against this

The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
forwardwritten 2026-10-06
C16management claimmedium confidence
Management says its lead wafer-level AI customer moved all production burn-in from system-level test to wafer level and doubled its systems; on August 12, 2026 it announced a $22M follow-on order from that customer, to ship over six months to its manufacturing partner in Taiwan.
against this

The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).

current state · 2026-08-12written 2026-10-06
C38facthigh confidence
Analysts' consensus, from two of them, is $135.2M for fiscal 2027 and $135.9M for 2028, flat; one analyst has $210.3M for 2029. All six ratings in FMP's series are buys, while the snapshot shows one buy and two holds.
current state · 2026-10-06written 2026-10-06
C11facthigh confidence
Cash, equivalents and restricted cash were $105.1M at September 25, 2026, against $116.5M at May 29, 2026 and $26.5M a year earlier, with no debt; $3.1M was used in operations in the quarter as long-lead parts were bought.
  1. 2026-11-03editedQ1 fiscal 2027 release and call: cash $105.1M at September 25, down $11.4M on working capital for long-lead parts; still no debt.
current state · 2026-09-25written 2026-10-06
C06management claimmedium confidence
Management says AI was about 71% of fiscal 2026 revenue and expects AI near 70% and silicon photonics 15% to 20% of fiscal 2027, with no memory revenue in the guide.
against this

The 10-K does not split revenue by AI end market; it gives systems, contactors and services, and wafer against package level (S01).

forwardwritten 2026-10-06
C37facthigh confidence
Over the 252 sessions to October 5 the price rose 223.7% while revenue per share fell 16%, so the multiple did all of it, up 285.5%; from the same starting close the price is up 72.6% at the October 22 close, with the multiple up about 105%. Trailing price to sales has a six-year median of 4.9.
  1. 2026-10-23editedre-struck at the 22 October close: the year's return and its split are recomputed from the pack's starting close
current state · 2026-10-22written 2026-10-06
C18management claimmedium confidence
Management says its hyperscale customer placed a record $41M Sonoma order in April, that a Sonoma system sells for about $600,000 to $700,000 with consumables, and that this customer plans a second device at twice the power. On the November 2 call management said it ships and installs more than a dozen Sonoma systems a month, that the customer's second processor has qualified on Sonoma with follow-on orders in October for an anticipated production ramp in calendar 2027, and that the customer forecasts it will reach higher volumes than the first.
against this

The customer is unnamed and no customer filing names Aehr (S01).

  1. 2026-11-03editedQ1 fiscal 2027 call: more than a dozen Sonoma systems a month, second processor qualified with follow-on orders; all still management's account of an unnamed customer.
current state · 2026-07-14written 2026-10-06

Where we disagree with the market

The market believes

Aehr is the AI burn-in winner: a forecast raised to triple last year, orders up sevenfold and the only wafer machine shown working on AI chips.

We believe

This year looks ordered. What the price adds on top rests on customers who have not ordered for production.

In 2023 Aehr forecast at least $100M of sales on one car-chip customer, cut that twice and delivered $66.2M; the shares fell from $54.10 to $9.83. Today's orders are cancellable, the buyers unnamed, and insiders sold into both rallies.

Against us: the forecast rose, orders beat sales, and a second large AI chip maker is buying a machine to test on its production line. If it orders for production, much of our view falls away.

What analysts say, and the evidence
Analysts positive
100%
of 6, 1 Oct
Four months earlier
75%
of 4, 1 Jun
The evidence under this - 6 claims
C36inferencehigh confidence
On 32.62M shares at $51.47 the market value is about $1.68B and, less $105.1M of cash, the company value about $1.57B: about 10.5 times the raised $150M guide and about 52 times its pretax target of at least 20% of revenue, $30M.
against this

The vendor put company value at $3.26B on an older share count, 63.9 times trailing sales at the October 5 close (S11); the share count here is still July's, and the first-quarter 10-Q will give the current one.

  1. 2026-10-23editedre-struck at the 22 October close of $55.65, 46.7% below the 5 October close it was struck at
  2. 2026-11-03editedRe-struck at the 2 November close of $51.47 (from $55.65) with September's cash of $105.1M and the raised $150M guide; the share count is still July's, the 10-Q not yet being filed.
current state · 2026-11-02written 2026-10-06
C38facthigh confidence
Analysts' consensus, from two of them, is $135.2M for fiscal 2027 and $135.9M for 2028, flat; one analyst has $210.3M for 2029. All six ratings in FMP's series are buys, while the snapshot shows one buy and two holds.
current state · 2026-10-06written 2026-10-06
C07facthigh confidence
Backlog was $80.6M at May 29, 2026, against $15.2M a year earlier, and $100.9M at September 25, 2026 after $33.0M of revenue in the quarter; the 10-K says most purchase orders can be cancelled or rescheduled with limited penalties.
  1. 2026-11-03editedQ1 fiscal 2027 release: backlog $100.9M at September 25; the cancellation terms are the 10-K's, and the quarter's 10-Q is not yet filed.
current state · 2026-09-25written 2026-10-06
C14facthigh confidence
In July 2023 Aehr guided fiscal 2024 to at least $100M of revenue and $28M of net income; it cut to $75M to $85M in January 2024 and to more than $65M in March, and delivered $66.2M.
historical · FY2024written 2026-10-06
C31facthigh confidence
Insiders made 74 open-market sales of 743,893 shares in the year to October 2026, none under a Rule 10b5-1 plan and with no purchases, clustered from April 9 to 22 at $66 to $100 and from August 12 to 17 at $127 to $144.
current state · 2026-10-06written 2026-10-06
C19management claimmedium confidence
Management says a major supplier of AI accelerators, CPUs and network processors completed a wafer-level benchmark that beat expectations and has now decided to buy one FOX-XP test cell to evaluate in a high-volume production setting at its Taiwan assembly partner, installed in early calendar 2027 with a production decision expected within several months after; it contributes about nothing to the fiscal 2027 guide.
against this

The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
forwardwritten 2026-10-06
06

What could go wrong, and how we would know

The risks

  • A few buyers Three customers were half of last year's sales and the forecast rests on two unnamed buyers whose orders can be cancelled.
  • Rivals for finished chips AEM and others already sell burn-in for finished AI chips, and one large designer chose AEM.
  • Margins under pressure Gross margin recovered to 48.5% in the latest quarter from 35.3% last year, but suppliers of power parts raised prices 40%, management says.
  • Chinese copies A Chinese rival sells a similar wafer machine and won the first court round; the appeal is pending.
  • Orders can slip In fiscal 2024 one customer's slower orders cut the forecast by a third within nine months.
The evidence under this - 8 claims
C04facthigh confidence
The five largest customers were 70% of fiscal 2026 revenue, against 77% in 2025 and 93% in 2024; three customers were 26%, 14% and 11% in 2026, and in 2024 two were 67% and 17%.
historical · FY2026written 2026-10-06
C16management claimmedium confidence
Management says its lead wafer-level AI customer moved all production burn-in from system-level test to wafer level and doubled its systems; on August 12, 2026 it announced a $22M follow-on order from that customer, to ship over six months to its manufacturing partner in Taiwan.
against this

The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).

current state · 2026-08-12written 2026-10-06
C07facthigh confidence
Backlog was $80.6M at May 29, 2026, against $15.2M a year earlier, and $100.9M at September 25, 2026 after $33.0M of revenue in the quarter; the 10-K says most purchase orders can be cancelled or rescheduled with limited penalties.
  1. 2026-11-03editedQ1 fiscal 2027 release: backlog $100.9M at September 25; the cancellation terms are the 10-K's, and the quarter's 10-Q is not yet filed.
current state · 2026-09-25written 2026-10-06
C24factmedium confidence
Semight and Nexustest each sell a nine-wafer burn-in system for silicon carbide and gallium nitride wafers under the same model numbers, and Pentamaster sells a six-to-eight-wafer one; none of the three pages offers wafer-level burn-in of AI processors.
current state · 2026-10-06written 2026-10-06
C25factmedium confidence
Package-level burn-in for AI chips is sold by others: AEM says its AMPS-BI was chosen as the plan-of-record by a major fabless AI chip maker in 2024; Advantest sells a system-level test and burn-in platform; Trio-Tech's burn-in board sales rose 58.4% in its year to June 2026.
current state · 2026-09-24written 2026-10-06
C10facthigh confidence
Fiscal 2026 gross margin was 35.3%, down 5.3 points on assembly, warranty, freight and tariffs; research cost $12.6M and selling and administration $19.2M, for an operating loss of $14.1M and a net loss of $7.1M after a $4.6M tax benefit.
historical · FY2026written 2026-10-06
C43management claimmedium confidence
Management says power supply vendors raised prices 40%, and that consumables run about 30% of revenue.
against this

Contactors were $14.9M of $50.0M, 30%, in fiscal 2026 (C03), which agrees; the 40% is not in the 10-K.

current state · 2026-07-14written 2026-10-06
C23facthigh confidence
A Chinese court dismissed Aehr's patent claims against Suzhou Semight in December 2025 for insufficient evidence; the appeal was heard on June 2, 2026, and management says a Taiwan silicon carbide customer chose Aehr over Semight.
current state · 2026-07-27written 2026-10-06
What we still do not know
  • Who the lead AI customer is, and how much more it plans to buy after the $22M order.
  • How big the burn-in market is: nobody outside the company measures it.
  • Whether the second AI chip maker in trials will order for production, and when.
  • Whether any memory maker will commit; management needs one before it builds the product.
The evidence under this - 4 claims
C16management claimmedium confidence
Management says its lead wafer-level AI customer moved all production burn-in from system-level test to wafer level and doubled its systems; on August 12, 2026 it announced a $22M follow-on order from that customer, to ship over six months to its manufacturing partner in Taiwan.
against this

The customer is unnamed, and EDGAR full-text search finds no filing by onsemi, Intel, TSMC or NVIDIA naming Aehr (S01).

current state · 2026-08-12written 2026-10-06
C27estimatemedium confidence
SEMI forecasts semiconductor test equipment sales up 31.0% to $15.3B in 2026 and $20.8B in 2028, after 55.3% in 2025, citing AI and high-bandwidth memory; it does not report burn-in separately.
against this

SEMI's 2025 figure moved from $11.2B to about $11.7B in seven months, and it counts all test equipment, not burn-in (S18, S19).

forwardwritten 2026-10-06
C19management claimmedium confidence
Management says a major supplier of AI accelerators, CPUs and network processors completed a wafer-level benchmark that beat expectations and has now decided to buy one FOX-XP test cell to evaluate in a high-volume production setting at its Taiwan assembly partner, installed in early calendar 2027 with a production decision expected within several months after; it contributes about nothing to the fiscal 2027 guide.
against this

The customer is unnamed and has not ordered; the last guide built on one customer's forecast was cut by a third (C14).

  1. 2026-11-03editedQ1 fiscal 2027 release and call: the benchmark customer moved from pilot validation to buying a test cell for production-scale evaluation; the production decision is still ahead.
forwardwritten 2026-10-06
C21management claimlow confidence
Management says it is in talks with two or three flash makers and two DRAM makers on wafer-level burn-in for memory, and needs a committed customer before it develops the product. On the November 2 call management said NAND flash opportunities are moving more slowly than expected, on limited new capacity and the timing of new flash designs, and that DRAM with logic in the base die may create wafer-level burn-in opportunities.
against this

No memory maker is named, and management says it will not build the product until one commits.

  1. 2026-11-03editedQ1 fiscal 2027 call: memory still no committed customer; NAND slower than expected.
forwardwritten 2026-10-06

What would change our view

  1. Unattractive→NeutralThe price falls back within 20% of fair value

    It needs:

    • ○The share price falls to about $11.04, back within 20% of what we think the business is worth.about ≈$8.43 today, 92% below the last close
  2. Unattractive→AttractiveThe price falls 20% under fair value

    It needs:

    • ○The share price falls to about $7.36, 80% of what we think the business is worth.about ≈$4.56 today, 96% below the last close
We would also be wrong if
  • A memory maker commits to wafer burn-in with an order.

What is coming

  • 6 November 2026 Q1 fiscal 2027 results: Whether revenue is ramping toward the $130M to $150M guide, what bookings did after the AI orders, and whether gross margin recovered.
Every dated event ahead
  • 6 November 2026 Q1 fiscal 2027 results: Whether revenue is ramping toward the $130M to $150M guide, what bookings did after the AI orders, and whether gross margin recovered.
  • 12 February 2027 Q2 fiscal 2027 results: The quarter management called its biggest, when most Sonoma systems ship; a miss there would break the guide.
  • 30 June 2027 Semight patent appeal ruling: Whether Aehr can stop its one named rival in China; a loss leaves the silicon carbide design open to copying.
Since we wrote this
Written
6 Oct
Price the thesis read
$104.40
5 Oct
  • 11 NovThesis reviewUnattractive, high conviction: the view holds even in our best caseConviction re-graded on the new anchors: how robust the view is, not whether anything is still open.
  • 9 NovThesis reviewUnattractive: priced at 573% of a value near $9.34Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
  • 3 NovEarningsGuide raised to $150M and price near 10.5 times it; now NeutralRecord $33.0M quarter, $46.7M of bookings and a test-cell purchase by the benchmark customer met route P2: the guide held while the price fell to about 10.5 times it.
  • 23 OctPrice movePrice re-struck: 12 times the guide, view heldThe shares fell 47% with no company news; the guide and the orders did not move, so the view waits for the 2 November results.
  • 8 OctNewsAehr's lead customer ordered more Sonoma systems; size and timing could not be read. View heldFollow-on Sonoma production orders from the lead hyperscale customer for its next-generation AI processor.
  • 6 OctThesis writtenUnattractive, medium convictionWritten three months after the fiscal 2026 print and its AI orders, with the shares back above $100 after a 47% fall and first-quarter results due in early November.

Also checked 5 times with nothing new to act on.

Sources 36

Where this came from

Sources - 36

Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.

  1. S01primarycompany filing2026-07-27
    the business description, revenue by category and line, concentration, end-market share, backlog, income statement, cash, the at-the-market sales, share count, deferred tax note, patents, legal proceedings and fiscal-year change
    backsC01C02C03C04C05C07C10C11C12C13C14C15C22C23C37C42C45
  2. S02primarycompany release2026-07-14
    fourth-quarter revenue and profit, record bookings, effective backlog, the fiscal 2027 guide, the benchmark customer and the photonics win
    backsC08C09C19C41
  3. S03primarycompany release2026-04-07
    the fiscal 2026 guide and the second-half bookings range
    backsC08C15
  4. S04primarytranscript2026-07-14
    Aehr fiscal 2026 fourth-quarter earnings call transcript (FMP)
    the AI share of revenue, the lead customer's move from system-level test, the yield argument, Sonoma pricing and the $41M order, the benchmark, memory talks, consumables, supplier prices and Nexus Test
    I believe that burn-in is by far the fastest growing segment in all of semiconductor test right now.
    backsC06C09C16C17C18C19C21C23C26C43C46
  5. S06primarycompany release2026-07-09
    the first automated system installed and a follow-on order
    This customer took delivery of its first FOX-XP with fully automated WaferPak Aligner production system in fiscal 2026.
    backsC20
  6. S07primarycompany release2026-08-04
    a nine-blade system at up to 3,500 watts a blade and its ship date
    The system is expected to ship during the first half of calendar 2027.
    backsC20C49
  7. S08primarycompany release2026-08-12
    the order size, what it contains and where it ships
    Aehr expects to ship the systems over the next six months for installation at the customer's high-volume manufacturing partner in Taiwan.
    backsC16
  8. S09primarycompany filing2026-10-06
    every open-market sale with its price, date, filer and Rule 10b5-1 flag
    backsC31
  9. S10primarycompany filing2026-09-09
    officers and their tenure, beneficial ownership, bonus outcomes and the share-unit targets
    backsC32C33C48
  10. S11secondaryvendor data2026-10-06
    AEHR research pack (FMP market tier and FINRA), frozen
    daily prices, the price-move decomposition, valuation history, analyst estimates and ratings, and short interest
    backsC34C35C36C37C38C39
  11. S13primarycompany filing2022-08-11
    fiscal 2022 revenue, costs and share count, and the named customers onsemi, Intel and others
    backsC02C05C13
  12. S14primarycompany release2023-07-13
    the fiscal 2024 guide of at least $100M and $28M of net income
    backsC14
  13. S15primarycompany release2024-01-09
    the guide cut to $75M to $85M
    backsC14
  14. S16primarycompany release2024-04-09
    the guide cut to more than $65M, made in March
    backsC14
  15. S18primaryindustry data2025-12-16
    test equipment sales for 2025 and the drivers SEMI names
    Sales of semiconductor test equipment are projected to surge 48.1% to $11.2 billion in 2025
    backsC27
  16. S19primaryindustry data2026-07-14
    test equipment sales for 2026 and 2028
    After surging 55.3% in 2025, semiconductor test equipment sales are projected to increase 31.0% to $15.3 billion in 2026
    backsC27
  17. S20primarytranscript2026-01-15
    TSMC fourth-quarter 2025 earnings call transcript (FMP) TSM
    AI accelerators' share of TSMC revenue and their forecast growth
    we raised our forecast for the revenue growth from AI accelerator to approach a mid- to high 50s percent CAGR for the 5 years period from 2024 to 2029.
    backsC28
  18. S21primarytranscript2026-07-16
    TSMC second-quarter 2026 earnings call transcript (FMP) TSM
    that AI accelerator demand ran ahead of the January forecast
    We don't give you the number today because it continue to increase, so we don't know how to answer this question. Stronger than what we said before.
    backsC28
  19. S22primaryother2020-06-01
    a buyer's account of why known-good die matter for chiplet packages
    Despite best efforts to produce KGD out of wafer test, there are still a significant number of defects that are being caught at package test
    backsC29
  20. S23primaryindustry data2021-03-01
    the reverse-bias qualification test and that it is a sample, not a production screen
    This sample size is NOT sufficient or intended for process control or PPM evaluation.
    backsC30
  21. S24primaryother2024-03-01
    wafer-level burn-in in onsemi's silicon carbide screening flow, vendor unnamed
    Electrical screening is implemented at multiple levels:
    backsC29
  22. S25primaryother2026-10-06
    a nine-wafer silicon carbide and gallium nitride burn-in system
    Simultaneously perform HTGB and HTRB burn-in tests on 9 wafers
    backsC24
  23. S26primaryother2026-10-06
    the same model numbers as Semight's
    WLBI3810 Wafer Level Burn-In System is a high-end burn-in test equipment specifically designed for Silicon Carbide (SiC) and Gallium Nitride (GaN) wafers
    backsC24
  24. S27primaryother2024-07-01
    a six-to-eight-wafer silicon carbide burn-in system
    The Trooper-BI series offers a comprehensive, fully automated solution for wafer-level silicon carbide burn-in
    backsC24
  25. S28primaryother2024-07-09
    a package-level burn-in rival chosen by an AI chip maker
    its burn-in test system has been selected as the Plan-of-Record solution by a major fabless provider of high-performance compute (HPC) and artificial intelligence (AI) semiconductor chips
    backsC25
  26. S29primaryother2026-10-06
    Advantest selling system-level test and burn-in together
    7038 High Parallelism System Level Test (SLT) and Burn-in (BI) Platform
    backsC25
  27. S30primarycompany filing2026-02-19
    what its system-level testers do, and no burn-in product
    backsC26
  28. S31primarycompany filing2026-09-24
    burn-in equipment and services, burn-in board growth and AI final test in Malaysia
    backsC25
  29. S33primarynews2001-01-01
    an early full-wafer burn-in programme at a buyer
    The result was that WLBT was as effective as conventional package level burn-in and did not degrade package reliability.
    backsC49
  30. S34primarycompany release2026-07-14
    the silicon carbide orders and the automaker
    Aehr also received a key order directly from one of the largest automotive companies in the world for multiple WaferPaks
    backsC44
  31. S35secondaryvendor data2026-10-22
    the 22 October 2026 close of $55.65
    backsC35C36C37
  32. S36primarycompany filing2026-11-02
    Q1 fiscal 2027 revenue, margins, bookings, backlog, cash at 25 September 2026 and the raised fiscal 2027 guide of $150M.
    backsC07C08C09C11C19C36C50
  33. S37primarytranscript2026-11-02
    Aehr Test Systems fiscal 2027 first quarter earnings call transcript (FMP), held 2026-11-02
    The benchmark customer's test-cell purchase and its timetable, Sonoma shipments of more than a dozen systems a month, memory progress, consumables at 41% of revenue, and the unit arithmetic per million processors.
    This customer has decided to purchase a full XP wafer level burn in test cell for installation at 1 of its key outsourced semiconductor assembly and test or OSAT partners in Taiwan. Where the system will be evaluated in a high volume production environment using the same device that was successfully tested in last quarter's benchmark.
    backsC08C11C18C19C21C50
  34. S38secondaryvendor data2026-11-02
    FMP end-of-day price history, AEHR, close of 2 November 2026
    The 2 November 2026 close of $51.47.
    backsC35C36
  35. S39primarycompany filing2026-11-09
    trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share count
    backsC52
  36. S40secondaryvendor data2026-11-09
    the analysts' average revenue and operating profit for the next three fiscal years, and the close
    backsC51C52
Rendered from content/AEHR/thesis.json · thesis reviewed 2026-11-03. This page explains a company; it does not say what to pay, when to buy or how much.